Free Trial

Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Acquired by SG Americas Securities LLC

Silicon Laboratories logo with Computer and Technology background

SG Americas Securities LLC increased its position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 1,106.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,791 shares of the semiconductor company's stock after purchasing an additional 21,819 shares during the quarter. SG Americas Securities LLC owned 0.07% of Silicon Laboratories worth $2,955,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Franklin Resources Inc. grew its holdings in Silicon Laboratories by 1.9% during the 3rd quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company's stock valued at $27,001,000 after buying an additional 4,278 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Silicon Laboratories during the 3rd quarter worth about $7,408,000. Intech Investment Management LLC increased its position in Silicon Laboratories by 82.9% during the 3rd quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company's stock worth $1,484,000 after purchasing an additional 5,818 shares in the last quarter. Barclays PLC lifted its holdings in Silicon Laboratories by 23.4% in the 3rd quarter. Barclays PLC now owns 70,568 shares of the semiconductor company's stock valued at $8,157,000 after purchasing an additional 13,363 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its holdings in Silicon Laboratories by 84.0% in the 2nd quarter. Clearbridge Investments LLC now owns 273,776 shares of the semiconductor company's stock valued at $30,288,000 after purchasing an additional 125,022 shares in the last quarter.

Insider Activity at Silicon Laboratories

In other news, Director William G. Bock sold 2,000 shares of Silicon Laboratories stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the sale, the director now owns 32,115 shares in the company, valued at $4,520,828.55. This trade represents a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.72% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on SLAB shares. Morgan Stanley cut their price objective on shares of Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating for the company in a research report on Tuesday, November 5th. KeyCorp boosted their price target on Silicon Laboratories from $115.00 to $160.00 and gave the company an "overweight" rating in a report on Wednesday. Barclays raised their price objective on Silicon Laboratories from $75.00 to $120.00 and gave the stock an "equal weight" rating in a report on Friday, January 17th. Stifel Nicolaus upped their target price on Silicon Laboratories from $135.00 to $145.00 and gave the company a "buy" rating in a research note on Monday, January 6th. Finally, Benchmark reissued a "hold" rating on shares of Silicon Laboratories in a research note on Tuesday, November 5th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Silicon Laboratories presently has a consensus rating of "Hold" and an average price target of $133.56.

Read Our Latest Stock Report on SLAB

Silicon Laboratories Stock Performance

Shares of NASDAQ:SLAB traded down $5.98 during trading on Friday, reaching $135.53. 240,445 shares of the stock were exchanged, compared to its average volume of 235,293. The firm's 50-day moving average price is $123.32 and its 200 day moving average price is $115.74. The firm has a market cap of $4.40 billion, a price-to-earnings ratio of -18.31 and a beta of 1.17. Silicon Laboratories Inc. has a 12-month low of $94.00 and a 12-month high of $154.91.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.07. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The company had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. During the same period in the previous year, the firm earned $0.48 earnings per share. Silicon Laboratories's revenue for the quarter was down 18.5% on a year-over-year basis. As a group, equities research analysts forecast that Silicon Laboratories Inc. will post -3.56 EPS for the current year.

Silicon Laboratories Profile

(Free Report)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

See Also

Institutional Ownership by Quarter for Silicon Laboratories (NASDAQ:SLAB)

Should You Invest $1,000 in Silicon Laboratories Right Now?

Before you consider Silicon Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.

While Silicon Laboratories currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

5 REITs Poised for Growth in 2025 – Top Real Estate Investments to Watch

5 REITs Poised for Growth in 2025 – Top Real Estate Investments to Watch

REITs to Watch in 2025! 📈 Brad Thomas, REIT Expert, Author, and Founder of Wide Moat Research, shares his top REIT picks for 2025.

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines